This article was revised on July 1, 2021, to update the coverage position.
AmeriHealth has resumed prior authorizations requirements for patients with a COVID-19 diagnosis effective July 1, 2021, for acute in-network inpatient admissions from the emergency department.
AmeriHealth resumed prior authorizations requirements for patients with and without a COVID-19 diagnosis as of April 1, 2021, for:
Transfers from acute in-network inpatient facilities to in-network post-acute facilities (long-term acute care hospitals, inpatient rehabilitation, skilled nursing facilities).
Transfers from acute in-network inpatient facilities to other in-network inpatient facilities and in-network ambulance transport.
Effective March 21, 2020, until 90 days after the end of both the Public Health Emergency and State of Emergency declared by the State of New Jersey in response to COVID-19, prior authorization will be waived for services delivered to AmeriHealth New Jersey members via telehealth/telemedicine regardless of diagnosis.
AmeriHealth will continue to assess the situation based on COVID-19 activity and share updates with our provider community.
AmeriHealth is committed to providing our members with access to the care they need during the COVID-19 pandemic. We encourage all AmeriHealth members and providers to visit our dedicated
AmeriHealth New Jersey and
AmeriHealth Pennsylvania COVID-19 webpages regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.
Facilities must continue to notify the AmeriHealth Utilization Management (UM) department within contractual time frames, but no longer than two business days from admission to an acute or post-acute facility.
The UM and Care Management departments will collaborate with facilities to gather clinical information and to assist in the coordination of transitions of care for members.
AmeriHealth retains the right to audit medical records, as warranted.